Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-10-06 | John Hernandez is a newly-nominated candidate for director. If elected, we expect to appoint him to our compliance oversight committee. ... Dr. Hernandez is clinical director and head of clinical research, health economics and outcomes research at Google, which is leveraging information technology and artificial intelligence to assist in promoting healthy lifestyles, diagnosing cancer, preventing blindness and much more. ... Dr. Hernandez was first recommended to us by a search firm retained by the nominating and governance committee. Dr. Hernandez’ experience in health economics and outcomes research in the medical device and digital health technologies industries led the board to conclude he should serve as a director. |
| 2022-10-05 | John Hernandez has served as a ResMed director since November 2021, and is a member of the compliance oversight committee. ... Fiscal year 2022 director compensation table ... John Hernandez $43,750 fees earned in cash, $249,975 option awards, total $293,725. |
| 2023-10-05 | John Hernandez has served as a ResMed director since November 2021, and is a member of the compliance oversight committee. ... Dr. Hernandez’ experience in health economics and outcomes research in the medical device and digital health technologies industries led the board to conclude he should serve as a director. |
| 2024-10-03 | John Hernandez | 57 Independent Head of Health Impact at Google Director since: 2021 Committees: Compliance Oversight |
Data sourced from SEC filings. Last updated: 2026-02-03